9FU-29987-59412
1 vaccination
1 coded response
7 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 606 / IL
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-21
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-22
Registered in v-safe
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-24
- 2021-03-25
-
2021-04-04
Survey response — day 14, dose 1MedDRA: Vomiting — Feeling: Poor · Be unable to do your normal daily activitiesFree text: VomitingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-04-11
- 2021-04-19
- 2021-06-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-21 | Janssen/Johnson & Johnson |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 6 — day 14, dose 1
Symptoms: Vomiting
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Vomiting | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release